NATAC
NAT | BME Growth
Overview
Corporate Details
- ISIN(s):
- ES0171613005
- LEI:
- 959800CAJAU3LNQW9246
- Country:
- Spain
- Address:
- AVA RITA LEVI MONTALCINI 14, 28906 Getafe
- Website:
- https://natacgroup.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
NATAC specializes in the production of natural ingredients and health solutions for the pharmaceutical sector.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
iDNA Genomics Public Ltd | Cyprus | IDNA | |
|
Idorsia Ltd | Switzerland | IDIA | |
|
ILIKA PLC | United Kingdom | IGE | |
|
Indivior PLC | United Kingdom | INDV | |
|
Infant Bacterial Therapeutics | Sweden | IBT | |
|
Initiator Pharma A/S | Denmark | INIT | |
|
Intercure Ltd. | Israel | INCR | |
|
Intervacc AB | Sweden | IVACC | |
|
Ipsen | France | IPN | |
|
J. Molner AS | Estonia | JML |